Relationship Between Loss of Y Chromosome and Urologic Cancers: New Future PerspectivesPierluigi Russo, Nazario Foschi, Filippo Gavi et al.|Cancers|2024Cited by 43
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicineFilippo Marino, Emilio Sacco, Angelo Totaro et al.|Prostate Cancer and Prostatic Diseases|2022Cited by 34
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic FactorsMatteo Santoni, Nicola Battelli, Daniel Y.C. Heng et al.|Cancers|2019Cited by 31
SIRI as a biomarker for bladder neoplasm: Utilizing decision curve analysis to evaluate clinical net benefitPierluigi Russo, Bernardo Rocco, Nazario Foschi et al.|Urologic Oncology Seminars and Original Investigations|2025Cited by 31